Investor Presentaiton
Q4 2020 reconciliation from management key metrics to IFRS
€m
Billings/Revenue
Cost of sales
Gross profit contribution
Sales
Marketing
Management view
adjusted P&L
Deferred
revenue
D&A
Other non-IFRS
adjustments
Accounting view
IFRS P&L
128.1
(7.2)
121.0
(9.6)/(7.5% of Billings)
118.5/(92.5% of Billings)
(7.7)
(0.2)
(17.5)/(14.5% of Revenue)
103.5/(85.6% of Revenue)
(16.7) / (13.0% of Billings)
(1.4)
(7.1)
(25.1)/(20.8% of Revenue)
(9.3)/(7.3% of Billings)
(0.4)
(1.6)
(11.2)/(9.3% of Revenue)
R&D
(10.7)/(8.4% of Billings)
(1.5)
(3.2)
(15.4)/(12.7% of Revenue)
G&A
(7.1)/(5.5% of Billings)
(0.5)
(5.0)
Other¹
(2.7)/(2.1% of Billings)
1.9
(12.6)/ (10.4% of Revenue)
(0.8)/(0.7% of Revenue)
Adj. EBITDA
D&A (ordinary only)2
Adj. EBIT/Operating profit (EBIT)
72.1/(56.3% of Billings)
(4.6)2
67.5/(52.7% of Billings)
(7.2)
(6.8)³
(15.1)
38.3/(31.7% of Revenue)
D&A (total)
11.5
EBITDA
Tincl. other income/expenses and bad debt expenses of €3.8m
2D&A excl. amortization intangible assets from PPA
3 amortization intangible assets from PPA
24
Q4/ FY 2020 Preliminary Results (unaudited) - Investor Presentation
49.8/ (41.2% of Revenue)
TeamViewerView entire presentation